We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Immunotherapy for Non-Hodgkin Lymphoma Passes Safety Test

News   Nov 02, 2018 | Original story from Stanford Medicine

 
Immunotherapy for Non-Hodgkin Lymphoma Passes Safety Test

Photo credit: Pixabay

 
 
 

RELATED ARTICLES

Leukemia Stem Cells Rely on Amino Acids for Survival

News

Clinically relevant eradication of leukemia stem cells could be achieved with drugs that target their metabolic vulnerabilities.

READ MORE

Molecular Mechanisms of Ancient Herbal Remedies

News

Analysis of leaf extract reveals novel chemistry for therapeutic ion channel activation.

READ MORE

Anti-Malaria Drugs Show Promise in Treating Cancer – Now We Know Why

News

Anti-malaria drugs known as chloroquines have been repurposed to treat cancer for decades, but until now no one knew exactly what the chloroquines were targeting when they attack a tumor. Now, researchers say they have identified that target - an enzyme called PPT1 - opening up a new pathway for potential cancer treatments.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cancer Research Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE